Illegal and Counterfeit Tobacco Products Seized in Peterborough Raid

Regulations by 2FIRSTS.ai

Feb.29.2024

Illegal and Counterfeit Tobacco Products Seized in Peterborough Raid

Thousands of suspected illegal and counterfeit tobacco products seized in Peterborough by joint police and council operation.

According to a recent report from the Peterborough Telegraph, thousands of suspected illegal and counterfeit tobacco products have been seized in a store and residential property in Peterborough, England.

According to a spokesperson for the Cambridgeshire Police, "Our East Community Team and Modern Slavery Team, in conjunction with Peterborough City Council's Trading Standards, Environmental Health and Housing Standards departments, visited shops and residences on Lincoln Road. Thousands of illegal and counterfeit tobacco products, including e-cigarettes and tobacco products, were seized. The Trading Standards department will continue with the investigation."

According to records, a total of nearly 11,000 illegal and counterfeit tobacco products were seized. The Peterborough City Council departments, which maintained close cooperation during the operation, will also continue to jointly conduct this enforcement investigation.

The Cambridge police department is advising the public that buying and using counterfeit tobacco is harmful to health and can also have negative effects on the legitimate market. They are committed to cracking down on illegal tobacco sales.

References:

[1] Thousands of suspected illegal cigarettes seized from shop in Peterborough's Lincoln Road

Also Read:

[1] Five Stores in Cumbria, UK, Found Selling Illegal E-cigarettes

[2] Action Taken by Adur and Worthing Council to Recycle Batteries

[3] Imperials Brands Stocks Fall Due to UK E-cigarette Tax

#Products #Illegal e-cigarettes #Counterfeit cigarettes #Various tobacco products #Product

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months

The U.S. Food and Drug Administration (FDA) has added Cytisinicline, a plant-based therapy developed by Achieve Life Sciences for nicotine vaping addiction, to its new National Priority Voucher (CNPV) program. The initiative shortens drug review timelines from 10–12 months to just 1–2 months, expediting approval for treatments that address major public health needs.

Oct.20 by 2FIRSTS.ai

Product | Dual-flavor, 30,000-puff SKE 2-in-1 launches across multiple UK distributor platforms.

E-cigarette brand SKE has listed its “30K Pro Max” bundle across multiple UK e-commerce platforms. The 2-in-1 device features dual flavors with a twist-to-switch design, draw activation, and mesh heating, with a claimed total of up to 30,000 puffs. Across several channels, single-unit pricing ranges from about £8.99 to £10.99.

Oct.24 by 2FIRSTS.ai

PMI Japan Unveils Limited-Edition IQOS ILUMA i “Galaxy Blue,” Priced Around $47

Philip Morris Japan announced it will release the limited-edition IQOS ILUMA i “Galaxy Blue” across IQOS stores nationwide starting October 29, priced at JPY 6,980 including tax (about USD 47). The new model features a space-themed design, with a members-only promotion to run at the Nagoya IQOS store.

Oct.29 by 2FIRSTS.ai

Study: TikTok Content Frames Nicotine Pouches as “Trendy Accessories,” Diluting Risk Perception Among Youth

A study published in JMIR Formative Research analyzed 132 TikTok videos related to nicotine pouches and found that platform content predominantly presents these products as a “youthful trend” rather than as smoking cessation tools. Health risks are underrepresented, the user base appears largely male, and this portrayal may influence how adolescents perceive the risks associated with nicotine products.